Loading…
Loading…
Are you seeing any changes in compliance or therapy for those GLP-1 OSA patients in the cohort you're tracking who have been with you for 3 years
Can you talk about the demand in initiatives that you have in place? And how do you measure which ones are really delivering
Can you talk us through in terms of each of the factors that attributed to the expansion? How much of it was driven by each?
Can you point out if there is any, I guess, bulk purchases or one-offs that might have occurred this quarter
Can you comment a little bit on the production of AirSense 11?